IDF2022-1255 Efficacy and safety of finerenone by age and sex subgroups in patients with chronic kidney disease and type 2 diabetes

Autor: Bansal, S., Anker, S., Bakris, G., Filippatos, G., Rossing, P., Ruilope, L., Birne, R., Canziani, M., Farjat, A., Brinker, M., Pitt, B.
Zdroj: In Diabetes Research and Clinical Practice March 2023 197 Supplement 1
Databáze: ScienceDirect